PCM
EHC icon

Prelude Capital Management’s Encompass Health EHC Stock Holding History

Prelude Capital Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,827
Closed -$782K – 1871
2022
Q1 		$782K Buy
13,827
+3,771
+38% +$197K 0.02% 679
2021
Q4 		$522K Hold
10,056
– – 0.01% 977
2021
Q3 		$600K Hold
10,056
– – 0.02% 800
2021
Q2 		$624K Buy
+10,056
New +$670K 0.02% 837
2014
Q1 		– Sell
-19,986
Closed -$530K – 1929
2013
Q4 		$530K Buy
+19,986
New +$556K 0.09% 332

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Prelude Capital Management's EHC Position: Q1 2026 in Review

Prelude Capital Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 3,942 shares — an estimated $418K sold.

Prelude Capital Management first reported a position in EHC in Q2 2013 and held it in 20 quarters. The position peaked at $1.81M in Q2 2021. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Prelude Capital Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 3,942 Encompass Health shares in Q1 2026, an estimated $418K.
  • Prelude Capital Management first reported a position in Encompass Health in Q2 2013 and held it in 20 quarters.
  • Prelude Capital Management's Encompass Health position peaked at $1.81M in Q2 2021.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.